News Center

Discover all of the trending news of the Ipsen Group


12 results

Rare diseases

Ipsen and Blueprint enter exclusive agreement in FOP

Today, Ipsen announced it has entered into an exclusive, worldwide agreement with Blueprint Medicines…

Oncology

Rethink liver cancer: Increase your understanding this Liver Cancer Awareness Month

This Liver Cancer Awareness Month, we challenge you to rethink liver cancer. Learn more about…

Oncology

Ipsen in Oncology: For us, it’s personal

September 27, 2019

[caption id="attachment_6649" align="aligncenter" width="589"] Bartek BEDNARZ, SVP Global Product and Portfolio Strategy, IPSEN[/caption] At…

Innovation

How data analysis can outpace the lab to answer clinically pressing questions

September 20, 2019

[caption id="attachment_5663" align="alignnone" width="226"] Ulf Staginnus, SVP, Head Global Market Access & Pricing at Ipsen[/caption]…

Innovation Patient

#WeWontRest in using digital innovation to transform patients’ lives

September 16, 2019

[caption id="" align="aligncenter" width="262"] Harout Semerjian, EVP, Chief Commercial Officer, Ipsen[/caption] The European Federation…

Financial information

Ipsen will hold a conference call Thursday, 25 July 2018 at 2:30 p.m. (Paris time).

Participants should dial in to the call approximately five to ten minutes prior to its…

Patient

COSMIC-021 trial

As part of Ipsen’s ongoing commitment to improve outcomes for patients with high unmet medical…

Innovation

Fulfilling our Bold Promise Through External Innovation

Ivana Magovčević-Liebisch Ph.D., J.D. Executive Vice-President, Chief Business Officer It has just been…

Oncology

It’s time to talk about kidney cancer!

World Kidney Cancer Day is on 20 June, an event created by the International Kidney…

Innovation

How Ipsen is making patient-centric innovation a reality

Bartek Bednarz, Ipsen, Senior Vice-President, Oncology Franchise The world of healthcare is changing. Patients are…

Event Financial information

Ipsen – Investor Day 2019

To register for the webcast, please Click here.

Patient

Standby statement on lanreotide generic

Paris (France), April 29, 2019 - Following information regarding the filing of a generic…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020